That's life in the stock market.
Many here pulling numbers of $2 out of the air have been gazumped by real investors putting real money on the table. The same silly threads have been posted in a few of my holdings subject to takeover. LNK/SYD are other cases in point where retail punters pluck out a SP number they like and expect reasonably diligent buyers to stump up real cash.
In relation to API :-
I have expressed my resentment to retail juggernauts WES and then WOW being able to control healthcare/distribution in Australia assuming community obligations. They are in business just to profit. Ethics does not enter the discussion of the biggest retailers.
I sold a fair proportion of my API in the $1.70s in order to fund the purchase of fallen market darling MFG and top up SIG in the low 40s. More good luck than good management I must say.
I would prefer the API Board resist any takeover at all, but clearly they don't believe they can add any more value for shareholders even though that is their job. As an owner of LYC I was glad Amanda Lacaze stood up to Scott and told WES to go away. A 400% price gain since the low ball offer, was the shareholder reward.
So the current and future business potential and share value is worth $1.55. $2? "Tell him he's dreaming"
I will be a reluctant seller of a community based business in a community based industry by way way of compulsory acquisition rules.
Not happy but moving on, there are still many battles to be won in the interests of small shareholders.
GLTA
Anyone wanting Australian Pharmaceutical Industries will need at least to start at $2, page-14
Add to My Watchlist
What is My Watchlist?